Patent ID: 7517658

Claim:
A method for preparing a composition which comprises: (a) determining whether a chemical compound is a human SNORF33 receptor agonist which comprises contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein the cells prior to being transfected with the DNA do not express the human SNORF33 receptor, with the compound under conditions permitting the activation of the human SNORF33 receptor, and detecting any increase in human SNORF33 receptor activation, so as to thereby determine whether the compound is a human SNORF33 receptor agonist; (b) recovering the compound free of any human SNORF33 receptor; and (c) admixing the compound with a pharmaceutically acceptable carrier; wherein the human SNORF33 receptor has the amino acid sequence identical to that shown in SEQ ID NO: 6 or that encoded by plasmid pcDNA3.1-hSNORF33-f (ATCC Patent Deposit Designation PTA-398) or plasmid pEXJ-hSNORF33-f (ATCC Patent Deposit Designation PTA-570).